Cannabis (September/October)

Date of Issue: 08/10/2023 | Volume: 10 | Number: 6&7

Issue Links:Learning Objectives | Editorial Information

Dr. Walker describes features of cannabis use disorder and the effects of withdrawal while Dr. D’Souza discusses risks of emerging medicinal cannabis legislation. We delve into the world of dispensaries and review the cannabis products that are available to our patients. Plus, updates on research findings into the efficacy of cannabis in PTSD, and treatment approaches to gambling and OUD.

In This Issue

Clinical Update

Currently Available Cannabis Products

Topics: Cannabis | cannabis products | dispensary

The sale of medical and recreational cannabis products has become big business as the prevalence of cannabis use increases across the country. There has been an explosion in the number of available products and their potency. Here, we go over what sorts of products are on the market now and what the implications for our patients.

Read More
Expert Q&A

Cannabis Use Disorder and Withdrawal

Topics: Behavioral therapy | Cannabis | cannabis use disorder | cannabis withdrawal

Dr. Walker reviews the clinical features of cannabis use disorder, who is most at risk, how it is similar and how it differs from other addictions, and treatment approaches. She also describes cannabis withdrawal, a syndrome that can pose a barrier to treatment, but frequently goes unrecognized.

Read More
Expert Q&A

Medicinal Cannabis

Topics: Cannabis | Legal issues | medicinal cannabis

Laws permitting the use of cannabis for medicinal purposes are being passed around the country, but what are we to make of this new and evolving legal patchwork? Dr. D’Souza describes the process and implications of state-specific legislation, and reviews the evidence, or lack thereof, for cannabis treatment of psychiatric disorders.

Read More
Research Update

Can Smoking Marijuana Reduce PTSD Symptoms?

Topics: Cannabis | Double blind trial | PTSD

Many states have passed laws allowing the prescription of cannabis as a treatment for PTSD in spite of the absence of high-quality evidence. In this prospective, double-blinded trial, researchers failed to find evidence that either THC or CBD is an effective treatment for PTSD.

Read More
Research Update

Sublocade vs SL Buprenorphine after Release from Jail

Topics: Buprenorphine | Incarceration | long-acting buprenorphine | OUD

The period immediately following release from incarceration is associated with an elevated risk of overdose among those with opioid use disorder. In this randomized trial, researchers were able to show that long-acting injectable buprenorphine (Sublocade) is a feasible and effective treatment for this high-risk population.

Read More
Research Update

Internet-Based Approaches for Gambling Issues

Topics: Behavioral therapy | gambling | internet-based treatment

Problematic gambling is quite common, but many patients never receive any treatment. Hypothesizing that part of the reason for this is a lack of accessibility, researchers investigated the utility of internet-based gambling treatments. While not as effective as in-person treatment, the results were promising.

Read More
Research Update

Computer-Based Training for CBT for Women in Residential Treatments

Topics: Cognitive Behavioral Therapy | Computers in Psychiatric Practice | internet-based treatment | open label trial

Numerous studies have established the efficacy of Cognitive Behavioral Therapy (CBT) for a variety of psychiatric diagnoses. How effective CBT can be when delivered on a computer is an ongoing area of study. Here, researchers find that an internet-based CBT protocol was a helpful adjunctive treatment in a residential setting.

Read More
CME Post-Test

CME Post-Test - Cannabis, CATR, September/October 2022

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 2 CME Credits.

Read More